CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)
- Previous Close
32.82 - Open
35.40 - Bid 31.99 x --
- Ask 32.00 x --
- Day's Range
31.00 - 33.00 - 52 Week Range
9.09 - 40.62 - Volume
13,510,807 - Avg. Volume
15,069,971 - Market Cap (intraday)
44.961B - Beta (5Y Monthly) -0.22
- PE Ratio (TTM)
62.76 - EPS (TTM)
0.51 - Earnings Date --
- Forward Dividend & Yield 0.32 (1.00%)
- Ex-Dividend Date Apr 25, 2024
- 1y Target Est
40.98
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of functional foods in the field of general health in China and internationally. It offers functional raw materials, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikangwei C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
www.xnwpharma.net1,887
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 300765.SZ
Performance Overview: 300765.SZ
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300765.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300765.SZ
Valuation Measures
Market Cap
44.96B
Enterprise Value
42.27B
Trailing P/E
63.24
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
19.38
Price/Book (mrq)
10.20
Enterprise Value/Revenue
18.32
Enterprise Value/EBITDA
50.52
Financial Highlights
Profitability and Income Statement
Profit Margin
30.57%
Return on Assets (ttm)
7.51%
Return on Equity (ttm)
14.00%
Revenue (ttm)
2.31B
Net Income Avi to Common (ttm)
705.32M
Diluted EPS (ttm)
0.51
Balance Sheet and Cash Flow
Total Cash (mrq)
2.69B
Total Debt/Equity (mrq)
0.03%
Levered Free Cash Flow (ttm)
960.3M
Research Analysis: 300765.SZ
Company Insights: 300765.SZ
300765.SZ does not have Company Insights